|
* SMi's Clinical Trials in CNS conference is now in its 9th year - click below to view our 2010 event *
2009 Past Event Details:
“The topics of the lectures are well balanced, and the speakers are selected very well. It was a pleasure to participate. Thank you.”
Petr Kopecek, Clinical Scientist, Boehringer Ingelheim, SMi’s 2008 Clinical Trials in CNS Conference
More than 26 million people worldwide were estimated to be living with Alzheimer's disease in 2006, and it is estimated that the global prevalence of Alzheimer's disease will grow to more than 106 million by 2050. SMi’s 8th annual event on Clinical Trials in CNS, will look at new advances in the treatment of this disorder of the central nervous system, as well as examining others.
Experts will consider emerging disease targets, use of biomarkers and imaging techniques in clinical trials, cognitive testing, translational medicine, as well as safety and regulatory issues. There will also be an update on progress of the recent Alzheimer's Disease Neuroimaging Initiative (ADNI).
Why should you attend this event?
- GAIN insight into appropriate safety measures
- HEAR the latest progress of ADNI
- UNDERSTAND how to design better CNS trials
- EVALUATE different end-point methods
- DISCOVER recent advances in disease method understanding and target identification
Hear keynote addresses from:
- Steve Jacobsen, Associate Director, Neuroscience Discovery, Wyeth
- Magnus Sjogren, Global Head Translational Medicine, Schering-Plough
- Mark Schmidt, Senior Director and Clinical Expert CNS, Johnson & Johnson
Our expert speaker line-up also includes:
- Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition
- Karl Herholz, Professor of Clinical Neuroscience, University of Manchester
- Babak Boroojerdi, Senior Director, UCB
- Sophie Dix, Senior Research Scientist, Eli Lilly
- Jean-Louis Abitbol, Chief Medical Officer, Trophos
- Judith Dunn, Vice President, Clinical Development, Flexion Therapeutics
- Nicola Scott, Principal Statistician, Discovery Biometrics, Neurosciences, GlaxoSmithKline
- Marie Luby, Post-doctoral Scientist, National Institute of Neurological Disorders and Stroke, National Institutes of Health
- Erik Buntinx, Chief Executive, PharmaNeuroBoost
- Keith Wesnes, Practice Leader, United BioSource Corporation
- Remy Luthringer, Chief Executive, Forenap
- Alan Kott, Clinical Director, United BioSource Corporation
- Malcolm Barratt-Johnson, Managing Partner, The BJ Partnership
- Jill Rasmussen, Director, psi-napse
- Alan Gelenberg, President & CEO, Healthcare Technology Systems LLC
- Julian Aralica, Chief Executive Officer, Altoria
- Ruth Itzhaki, Professorial Fellow in Molecular Neurobiology, University of Manchester
Who should attend?
- Clinical Trials Directors
- Medical Directors
- Clinical Development Directors
- Clinical Research Directors
- Senior Scientists
- Chief Scientific Officers
Organisations registered so far this year include:
- Averion International
- BTG
- Celentyx
- Cytox
- Eisai
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Imperial College
- Lundbeck
- Merck Sharp & Dohme
- NeuroSearch
- Noscira
- Otsuka Pharmaceutical
- Pharmaneuro Boost
- Proximagen
- Roche Products
- Schering-Plough
- Takeda Europe
- Teva Pharmaceuticals
- UK Trade and Investment
|
|
Venue details
|
Crowne Plaza St James London
.
45-51 Buckingham Gate
London
SW1E 6AF
Tel: +44 (0) 207 834 6655
Fax: +44 (0) 207 834 6307
|
.
.
|
|
Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs. In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.
The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu. A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car
Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)
From St. James's Park Underground Station to the Hotel
Take the main St James’s Park exit and turn left into Petty France Street.
Continue Straight down for 200 yards and at the end turn left into Buckingham Gate
SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive room / night for single occupancy
Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.
Conference Documentation
SMi provide a wide range of conference documentation which allows you to benefit from the invaluable information shared by our expert speakers now and in the future. Our Hard Copy Documentation and CD ROMs, PLUS NEW CD Collections provides you with timely information valuable to your industry, which can be used as a future reference tool. Our conference fee includes a copy of the event proceedings in both hard copy and CD ROM.
CD Collections
SMi are proud to present our Clinical Trials Collection CD ROM. It will provide you with all the latest information on this subject, plus allows you to look back over the previous year's developments.
This collection includes:
- Clinical Trial Logistics 2009
- Clinical Trials in Cancer 2009
- Paediatric Clinical Trials 2009
- Conducting Clinical Trials in Europe 2008
- Clinical Trials in CNS 2008
Purchase this collection and benefit from having 5 events on 1 disc and a 20% saving.
|
Events Home Page
